Page 150 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 150
64. Kindrick AV, Grossfeld GD, Stier DM, et 74. Mettlin CJ, Murphy GP, McGinnis LS, et al.
al. Use of imaging tests for staging newly The National Cancer Data Base report on
diagnosed prostate cancer: trends from the prostate cancer. American College of
CaPSURE database. J Urol 1998;160:2102- Surgeons Commission on Cancer and the
2106. American Cancer Society. Cancer
65. Cooperberg MR, Lubeck DP, Grossfeld GD, 1995;76:1104-1112.
et al. Contemporary trends in imaging test 75. Mettlin CJ, Murphy GP, Rosenthal DS, et al.
utilization for prostate cancer staging: data The National Cancer Data Base report on
from the cancer of the prostate strategic prostate carcinoma after the peak in
urologic research endeavor. J Urol incidence rates in the U.S. The American
2002;168:491-495. College of Surgeons Commission on Cancer
66. Harlan SR, Cooperberg MR, Elkin EP, et al. and the American Cancer Society. Cancer
1998;83:1679-1684.
Time trends and characteristics of men
choosing watchful waiting for initial 76. Danley KL, Richardson JL, Bernstein L, et
treatment of localized prostate cancer: al. Prostate cancer: trends in mortality and
results from CaPSURE. J Urol stage-specific incidence rates by
2003;170:1804-1807. racial/ethnic group in Los Angeles County,
California (United States). Cancer Causes
67. Cooperberg MR, Lubeck DP, Meng MV, et Control 1995;6:492-498.
al. The changing face of low-risk prostate
cancer: trends in clinical presentation and 77. Hamilton AS, Albertsen PC, Johnson TK, et
primary management. J Clin Oncol al. Trends in the treatment of localized
2004;22:2141-2149. prostate cancer using supplemented cancer
registry data. BJU Int 2011;107:576-584.
68. Cooperberg MR, Broering JM, Kantoff PW,
et al. Contemporary trends in low risk 78. Smart CR. The results of prostate carcinoma
prostate cancer: risk assessment and screening in the U.S. as reflected in the
treatment. J Urol 2007;178:S14-S19. surveillance, epidemiology, and end results
program. Cancer 1997;80:1835-1844.
69. Cooperberg MR, Broering JM, Carroll PR.
Time trends and local variation in primary 79. Merrill RM, Feuer EJ, Warren JL, et al. Role
treatment of localized prostate cancer. J Clin of transurethral resection of the prostate in
Oncol 2010;28:1117-1123. population-based prostate cancer incidence
rates. Am J Epidemiol 1999;150:848-860.
70. Shah JB, McKiernan JM, Elkin EP, et al.
Prostate biopsy patterns in the CaPSURE 80. Hsing AW, Tsao L, Devesa SS.
database: evolution with time and impact on International trends and patterns of prostate
outcome after prostatectomy. J Urol cancer incidence and mortality. Int J Cancer
2008;179:136-140. 2000;85:60-67.
71. Greene KL, Cowan JE, Cooperberg MR, et 81. Mariotto AB, Wesley MN, Cronin KA, et al.
al. Who is the average patient presenting Estimates of long-term survival for newly
with prostate cancer? Urology 2005;66:76- diagnosed cancer patients: a projection
82. approach. Cancer 2006;106:2039-2050.
72. Mettlin CJ, Murphy G. The National Cancer 82. Abdollah F, Sun M, Thuret R, et al. A
Data Base report on prostate cancer. Cancer competing-risks analysis of survival after
1994;74:1640-1648. alternative treatment modalities for prostate
cancer patients: 1988-2006. Eur Urol
73. Mettlin CJ, Murphy GP, Ho R, et al. The 2011;59:88-95.
National Cancer Data Base report on
longitudinal observations on prostate cancer. 83. Paltoo DN, Chu KC. Patterns in cancer
Cancer 1996;77:2162-2166. incidence among American Indians/Alaska
Natives, United States, 1992-1999. Public
Health Rep 2004;119:443-451.
96
